90 related articles for article (PubMed ID: 10361181)
1. Follow-up of patients with a thin melanoma.
Johnson RC; Fenn NJ; Horgan K; Mansel RE
Br J Surg; 1999 May; 86(5):619-21. PubMed ID: 10361181
[TBL] [Abstract][Full Text] [Related]
2. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
[TBL] [Abstract][Full Text] [Related]
3. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy.
Zapas JL; Coley HC; Beam SL; Brown SD; Jablonski KA; Elias EG
J Am Coll Surg; 2003 Sep; 197(3):403-7. PubMed ID: 12946795
[TBL] [Abstract][Full Text] [Related]
4. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm.
Cohn-Cedermark G; Rutqvist LE; Andersson R; Breivald M; Ingvar C; Johansson H; Jönsson PE; Krysander L; Lindholm C; Ringborg U
Cancer; 2000 Oct; 89(7):1495-501. PubMed ID: 11013363
[TBL] [Abstract][Full Text] [Related]
5. Thick melanoma: the challenge persists.
Murray CS; Stockton DL; Doherty VR
Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
[TBL] [Abstract][Full Text] [Related]
6. Analysis of local recurrence and optimizing excision margins for cutaneous melanoma.
Ng AK; Jones WO; Shaw JH
Br J Surg; 2001 Jan; 88(1):137-42. PubMed ID: 11136327
[TBL] [Abstract][Full Text] [Related]
7. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
Finley JW; Gibbs JF; Rodriguez LM; Letourneau R; Driscoll D; Kraybill W
Am Surg; 2000 Jun; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
[TBL] [Abstract][Full Text] [Related]
8. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick).
Khayat D; Rixe O; Martin G; Soubrane C; Banzet M; Bazex JA; Lauret P; Vérola O; Auclerc G; Harper P; Banzet P;
Cancer; 2003 Apr; 97(8):1941-6. PubMed ID: 12673721
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy and early-stage melanoma.
Daryanani D; Plukker JT; De Hullu JA; Kuiper H; Nap RE; Hoekstra HJ
Cancer; 2003 May; 97(9):2248-53. PubMed ID: 12712479
[TBL] [Abstract][Full Text] [Related]
10. Follow-up schedules after treatment for malignant melanoma.
Francken AB; Accortt NA; Shaw HM; Colman MH; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
Br J Surg; 2008 Nov; 95(11):1401-7. PubMed ID: 18844268
[TBL] [Abstract][Full Text] [Related]
11. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis.
Livestro DP; Kaine EM; Michaelson JS; Mihm MC; Haluska FG; Muzikansky A; Sober AJ; Tanabe KK
Cancer; 2007 Aug; 110(3):614-24. PubMed ID: 17577228
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
13. An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis.
Einwachter-Thompson J; MacKie RM
Br J Dermatol; 2008 Aug; 159(2):337-41. PubMed ID: 18510665
[TBL] [Abstract][Full Text] [Related]
14. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.
Moore Dalal K; Zhou Q; Panageas KS; Brady MS; Jaques DP; Coit DG
Ann Surg Oncol; 2008 Aug; 15(8):2206-14. PubMed ID: 18512102
[TBL] [Abstract][Full Text] [Related]
15. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
16. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
[TBL] [Abstract][Full Text] [Related]
17. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.
Dalal KM; Patel A; Brady MS; Jaques DP; Coit DG
Ann Surg Oncol; 2007 Jun; 14(6):1934-42. PubMed ID: 17406951
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
[TBL] [Abstract][Full Text] [Related]
19. Melanomas in renal transplant recipients.
Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
[TBL] [Abstract][Full Text] [Related]
20. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.
Karavitaki N; Brufani C; Warner JT; Adams CB; Richards P; Ansorge O; Shine B; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2005 Apr; 62(4):397-409. PubMed ID: 15807869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
